McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization
McKesson will acquire Precision Medicine Group for $2.25 billion, expanding its clinical research and drug commercialization services.
Read original at benzingaStocks · News reference
McKesson Raises Quarterly Dividend From $0.82 To $0.94 Per Share
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.94 per share of common stock, a 15% increase from $0.82 per share in the prior quarter. The dividend will be payable
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 22, 2026, 12:04 PM
- Checked
- Jul 22, 2026, 12:04 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
McKesson To Acquire Precision Medicine Group For ~$2.25
Read original at benzingaBarclays Maintains Overweight on McKesson, Raises Price Target to $1000
Barclays analyst Glen Santangelo maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $925 to $1000.
Read original at benzingaRBC Capital Initiates Coverage On McKesson with Sector Perform Rating, Announces Price Target of $845
RBC Capital analyst Ryan Halsted initiates coverage on McKesson (NYSE:MCK) with a Sector Perform rating and announces Price Target of $845.
Read original at benzinga